Cargando…
Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis
Dermatitis herpetiformis (DH) is an inflammatory skin disorder often considered as an extra intestinal manifestation of celiac disease (CeD). Hallmarks of CeD and DH are auto‐antibodies to transglutaminase 2 (TG2) and transglutaminase 3 (TG3), respectively. DH patients have auto‐antibodies reactive...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477854/ https://www.ncbi.nlm.nih.gov/pubmed/37424036 http://dx.doi.org/10.1002/advs.202300401 |
_version_ | 1785101224281899008 |
---|---|
author | Das, Saykat Stamnaes, Jorunn Kemppainen, Esko Hervonen, Kaisa Lundin, Knut E. A. Parmar, Naveen Jahnsen, Frode L. Jahnsen, Jørgen Lindfors, Katri Salmi, Teea Iversen, Rasmus Sollid, Ludvig M. |
author_facet | Das, Saykat Stamnaes, Jorunn Kemppainen, Esko Hervonen, Kaisa Lundin, Knut E. A. Parmar, Naveen Jahnsen, Frode L. Jahnsen, Jørgen Lindfors, Katri Salmi, Teea Iversen, Rasmus Sollid, Ludvig M. |
author_sort | Das, Saykat |
collection | PubMed |
description | Dermatitis herpetiformis (DH) is an inflammatory skin disorder often considered as an extra intestinal manifestation of celiac disease (CeD). Hallmarks of CeD and DH are auto‐antibodies to transglutaminase 2 (TG2) and transglutaminase 3 (TG3), respectively. DH patients have auto‐antibodies reactive with both transglutaminase enzymes. Here it is reported that in DH both gut plasma cells and serum auto‐antibodies are specific for either TG2 or TG3 with no TG2–TG3 cross reactivity. By generating monoclonal antibodies from TG3‐specific duodenal plasma cells of DH patients, three conformational epitope groups are defined. Both TG2‐specific and TG3‐specific gut plasma cells have few immunoglobulin (Ig) mutations, and the two transglutaminase‐reactive populations show distinct selection of certain heavy and light chain V‐genes. Mass spectrometry analysis of TG3‐specific serum IgA corroborates preferential usage of IGHV2‐5 in combination with IGKV4‐1. Collectively, these results demonstrate parallel induction of anti‐TG2 and anti‐TG3 auto‐antibody responses involving separate B‐cell populations in DH patients. |
format | Online Article Text |
id | pubmed-10477854 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104778542023-09-06 Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis Das, Saykat Stamnaes, Jorunn Kemppainen, Esko Hervonen, Kaisa Lundin, Knut E. A. Parmar, Naveen Jahnsen, Frode L. Jahnsen, Jørgen Lindfors, Katri Salmi, Teea Iversen, Rasmus Sollid, Ludvig M. Adv Sci (Weinh) Research Articles Dermatitis herpetiformis (DH) is an inflammatory skin disorder often considered as an extra intestinal manifestation of celiac disease (CeD). Hallmarks of CeD and DH are auto‐antibodies to transglutaminase 2 (TG2) and transglutaminase 3 (TG3), respectively. DH patients have auto‐antibodies reactive with both transglutaminase enzymes. Here it is reported that in DH both gut plasma cells and serum auto‐antibodies are specific for either TG2 or TG3 with no TG2–TG3 cross reactivity. By generating monoclonal antibodies from TG3‐specific duodenal plasma cells of DH patients, three conformational epitope groups are defined. Both TG2‐specific and TG3‐specific gut plasma cells have few immunoglobulin (Ig) mutations, and the two transglutaminase‐reactive populations show distinct selection of certain heavy and light chain V‐genes. Mass spectrometry analysis of TG3‐specific serum IgA corroborates preferential usage of IGHV2‐5 in combination with IGKV4‐1. Collectively, these results demonstrate parallel induction of anti‐TG2 and anti‐TG3 auto‐antibody responses involving separate B‐cell populations in DH patients. John Wiley and Sons Inc. 2023-07-09 /pmc/articles/PMC10477854/ /pubmed/37424036 http://dx.doi.org/10.1002/advs.202300401 Text en © 2023 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Das, Saykat Stamnaes, Jorunn Kemppainen, Esko Hervonen, Kaisa Lundin, Knut E. A. Parmar, Naveen Jahnsen, Frode L. Jahnsen, Jørgen Lindfors, Katri Salmi, Teea Iversen, Rasmus Sollid, Ludvig M. Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis |
title | Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis |
title_full | Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis |
title_fullStr | Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis |
title_full_unstemmed | Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis |
title_short | Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis |
title_sort | separate gut plasma cell populations produce auto‐antibodies against transglutaminase 2 and transglutaminase 3 in dermatitis herpetiformis |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477854/ https://www.ncbi.nlm.nih.gov/pubmed/37424036 http://dx.doi.org/10.1002/advs.202300401 |
work_keys_str_mv | AT dassaykat separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis AT stamnaesjorunn separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis AT kemppainenesko separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis AT hervonenkaisa separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis AT lundinknutea separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis AT parmarnaveen separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis AT jahnsenfrodel separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis AT jahnsenjørgen separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis AT lindforskatri separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis AT salmiteea separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis AT iversenrasmus separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis AT sollidludvigm separategutplasmacellpopulationsproduceautoantibodiesagainsttransglutaminase2andtransglutaminase3indermatitisherpetiformis |